Alexa Nikiforou pens a personal essay on how quitting Ozempic forced her to confront the Latina beauty standards that have ...

Whether you are watching television, scrolling through Instagram, or catching up with an old friend, the topic of weight loss ...

We recently published a list of What Did Jim Cramer Say About These 19 Stocks Recently? In this article, we are going to take ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

The way they did it was to design a custom, synthetic cannabinoid molecule that is positively charged, which prevents it from being able to cross the blood-brain barrier. This means it can’t bind to ...

WITH DUPIXENT ... THAT THEY’VE DONE IN THE WAY THEY HANDLED THINGS LEADING UP TO THE ELECTION. IT’S AN INDICTMENT AGAINST ...

We recently published a list of 10 Worst Performing Large Cap Stocks to Buy According to Analysts. In this article, we are ...

DUPIXENT supported by positive APG990 interim Phase 1 results, which exceeded trial objectives and demonstrated potential for three- and six-month dosing in combination with APG777; APG279 readout ...

As Ant, O’Day sang “My Way,” by Frank Sinatra, followed by Coral singing the same. Ant/O’Day was ultimately voted out. Among O’Day’s early mentors was Sean “Diddy” Combs.” In last week’s voiceovers, ...

They include Sanofi/Regeneron's IL-4/IL-13 inhibitor Dupixent (dupilumab) and AZ's own IL-5 inhibitor Fasenra (benralizumab), which competes with GlaxoSmithKline's Nucala (mepolizumab) and Teva's ...